10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
View analysts' price targets and recommendations, and compare them with competitors.
$4.18
No peer data available for comparison.
Buy
Equal to THM's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
897.00M
The estimated revenue has increased from the previous period.
247.65M
The estimated EBITDA has increased from the previous period.
1.09
The estimated EPS has increased from the previous period.
363.49M
The estimated net income has increased from the previous period.
190.09M
The estimated EBIT has increased from the previous period.
630.50M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
349.76M
Revenue has increased from the previous period.
41.92%
Revenue growth rate has decreased from the previous period.
96.56M
EBITDA has decreased from the previous period.
27.61%
EBITDA margin has decreased from the previous period.
74.12M
EBIT has decreased from the previous period.
21.19%
EBIT margin has decreased from the previous period.
95.01M
Depreciation has increased from the previous period.
235.88M
Total cash has increased from the previous period.
67.44%
Cash percentage has increased from the previous period.
149.61M
Receivables have increased from the previous period.
42.77%
Receivables percentage has increased from the previous period.
162.63M
Inventories have increased from the previous period.
46.50%
Inventory percentage has increased from the previous period.
147.52M
Accounts payable has increased from the previous period.
42.18%
Payables percentage has increased from the previous period.
-88.58M
Capital expenditure has increased from the previous period.
-25.33%
CapEx percentage has increased from the previous period.
9.16%
WACC has increased from the previous period.
9.08%
Cost of equity is unchanged from the previous period.
293.12%
Cost of debt is unchanged from the previous period.
1.06
Beta is unchanged from the previous period.
333.90M
Diluted shares outstanding is unchanged from the previous period.
1.56M
Total debt is unchanged from the previous period.
3.49B
Total equity is unchanged from the previous period.
3.49B
Total capital is unchanged from the previous period.
0.04%
Debt weighting is unchanged from the previous period.
99.96%
Equity weighting is unchanged from the previous period.
45.79M
EBIAT has decreased from the previous period.
-93.45M
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
205.99M
Terminal value is unchanged from the previous period.
73.57M
Enterprise value has decreased from the previous period.
-113.70M
Net debt is unchanged from the previous period.
187.27M
Equity value has decreased from the previous period.
0.56
Equity value per share has decreased from the previous period.
